Advertisement

Topics

TapImmune, Inc. Company Profile

16:17 EST 12th December 2018 | BioPortfolio

TapImmune Inc. is an immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease. The Company’s vaccine compositions, peptide or nucleic acid-based, comprise one or multiple naturally processed epitopes (NPEs) designed to comprehensively stimulate a patients’ killer T-cells, helper T-cells and to restore or further augment antigen presentation by using proprietary nucleic acid-based expression systems. The Company’s vaccine compositions may be used as stand-alone medications or in combination with current treatment modalities. Please visit the Company’s website at www.tapimmune.com for details.


News Articles [11 Associated News Articles listed on BioPortfolio]

TapImmune gets $3.1mm through private placement ahead of merger

Cancer immunotherapies developer TapImmune Inc. sold 3.1mm common shares priced at $2.40 (an 18% discount) to its largest shareholder Eastern Capital, for gross proceeds of $3.1mm. The private placeme...

TapImmune and Marker Therapeutics to merge

TapImmune Inc. and privately held Marker Therapeutics Inc. agreed to a merger-of-equals transaction through which each immuno-oncology company will own approximately 50% of the new combined entity.

TapImmune aims for $70mm PIPE concurrent with closing of merger

TapImmune Inc. (cancer immunotherapies) priced a private placement of 17.5mm common shares at $4 apiece, for gross proceeds of $70mm. Piper Jaffray and Nomura are the placement agents. Completion of t...

TapImmune, Marker Therapeutics merge

TapImmune shares climb on $70M offering

After announced merger, TapImmune raises $70M

TapImmune (TPIV) Presents At 4th Annual Immuno-Oncology: BD&L And Investment Forum - Slideshow

TapImmune shares zoom on US$70mln private placement

The capital raise is timed to coincide with a planned merger with Market Therapeutics

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

TapImmune Inc.

TapImmune Inc. is an immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease. The Company’...

TapImmune, Inc.

TapImmune Inc. is an immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease. The Company’...

More Information about "TapImmune, Inc." on BioPortfolio

We have published hundreds of TapImmune, Inc. news stories on BioPortfolio along with dozens of TapImmune, Inc. Clinical Trials and PubMed Articles about TapImmune, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of TapImmune, Inc. Companies in our database. You can also find out about relevant TapImmune, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record